MedPath

CASA ESPIRITA TERRA DE ISMAEL

🇧🇷Brazil
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:4

Trial Phases

4 Phases

Phase 1:1
Phase 2:2
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (33.3%)
Phase 4
2 (33.3%)
Phase 1
1 (16.7%)
Phase 3
1 (16.7%)

Aesculus Hippocastanum L. on Fontan Circulation

Phase 2
Withdrawn
Conditions
Univentricular Heart
Interventions
Drug: Aesculus Hippocastanum / Horse Chestnut
Drug: Placebo
First Posted Date
2019-07-29
Last Posted Date
2021-01-28
Lead Sponsor
Casa Espirita Terra de Ismael
Registration Number
NCT04035317
Locations
🇧🇷

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, Sao Paulo, Brazil

Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis

Phase 4
Completed
Conditions
Effects of Immunotherapy
Atopic Dermatitis
Interventions
Drug: Mite extract sublingual immunotherapy (SLIT)
Other: Placebo
First Posted Date
2018-01-03
Last Posted Date
2020-08-26
Lead Sponsor
Casa Espirita Terra de Ismael
Target Recruit Count
91
Registration Number
NCT03388866
Locations
🇧🇷

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, Sao Paulo, Brazil

Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children

Phase 4
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Placebo
Drug: Probiatop
First Posted Date
2015-08-11
Last Posted Date
2021-01-28
Lead Sponsor
Casa Espirita Terra de Ismael
Target Recruit Count
60
Registration Number
NCT02519556
Locations
🇧🇷

Hospital das Clínicas FMRP-USP, Ribeirão Preto, São Paulo, Brazil

Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency

Phase 3
Completed
Conditions
Iron Deficiency Anemia
Interventions
Drug: Herbal medicine
First Posted Date
2011-08-11
Last Posted Date
2015-02-13
Lead Sponsor
Casa Espirita Terra de Ismael
Target Recruit Count
50
Registration Number
NCT01414374
Locations
🇧🇷

Laboratorio M. F. Teixeira, Monte Santo de Minas, Minas Gerais, Brazil

Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

Phase 2
Terminated
Conditions
Dyspepsia
Interventions
Drug: Maytenus ilicifolia leaves infusion
First Posted Date
2011-08-03
Last Posted Date
2016-07-26
Lead Sponsor
Casa Espirita Terra de Ismael
Target Recruit Count
4
Registration Number
NCT01408849
Locations
🇧🇷

Hospital das Clinicas FMRP-USP, Ribeirao Preto, SP, Brazil

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath